Weekly Venture Capital Activity Week Oct. 24 Through Oct. 30
Www. CapitalHunter. com was able to verify that $383 million of venture capital was invested in 35 U. S.-based companies during this week’s reporting period. The average deal size was approximately 10.94 million. The amount of venture capital invested this period increased by 4% compared to last periods $370 million.
San Diego, CA (PRWEB) November 4, 2005
It was a fairly normal week on the venture capital front, as California received the lion’s share of the funding, software and life sciences are still the industries of choice and pharmaceutical companies continue to attract large valuations. Cerimon Pharmaceuticals, a South San Francisco based biotechnology startup currently developing therapeutics for autoimmune diseases and inflammation, received a $70 million Series A investment which is to be used to diversify its product line via strategic partnerships and acquisitions. Another biotechnology company, Surface Logix, received a Series C investment of $32 million to further develop its Pharmacomer Technology Platform, which is used for drug optimization and development. Other biotechnology investments this week totaled an additional $31.85 million.
There were seven IPOs last week, however three of these offerings, Accentia Biopharmaceuticals, NxStage Medical and Mathstar, were venture-backed companies. These three companies (along with the other four) are listed below:
NCI priced at $54.075 million on the NASDAQ Stock Exchange and is a Reston, Virginia based provider of IT services to the U. S. government.
NxStage Medical priced at $55 million on the NASDAQ Stock Exchange and is a developer of medical devices for the treatment of ESRB and acute kidney failure.
Mathstar priced at $24 million on the NASDAQ Stock Exchange and is a developer of field programmable object arrays for electronic applications.
Hercules Offshore priced at $184 million on the NASDAQ Stock Exchange and is a provider of offshore drilling services to the energy industry.
Cogdell Spencer priced at $98.6 million on the New York Stock Exchange and is a real estate investment trust with stakes in medical office property.
Electro Optical Sciences priced at $20 million on the NASDAQ Stock Exchange and is a provider of medical devices used in the diagnosis of melanoma.
Accentia Biopharmaceuticals priced at $19.2 million on the NASDAQ Stock Exchange and is currently in late-stage clinical trials for next-generation pharmaceuticals used in the treatment of respiratory disease and oncology.
Www. CapitalHunter. com was able to verify that $383 million of venture capital was invested in 35 U. S.-based companies during this week’s reporting period. The average deal size was approximately 10.94 million. The amount of venture capital invested this period increased by 4% compared to last periods $370 million.
Once again, California was the most popular destination for venture capital. Thirteen California companies raised $192.45 million in new equity financing which was 50% of the total venture capital invested this reporting period. The largest private venture financing in California this period was invested into Cerimon Pharmaceuticals. Cerimon Pharmaceuticals raised $70 million and is a South San Francisco based provider of therapeutics for autoimmune disorders and inflammation.
The earlier mentioned biotechnology sector raised 35% of the venture capital this period. Five biotechnology companies raised $133.85 million in venture financing. The largest private venture financing into the biotechnology sector this period went into the aforementioned Cerimon Pharmaceuticals.
Companies raising their Series A financing round led this week’s venture capital activity. These financings represented 41% of the total venture capital deployed this period. The largest private venture financing was placed into the aforementioned Cerimon Pharmaceuticals.
The three largest venture deals this period are as follows:
1 Cerimon Pharmaceuticals Biotechnology $70 million
2 Surface Logix Biotechnology $32 million
3 Aruba Networks Networks & Equipment $25 million
The following fifteen companies and other unnamed investors funded the above mentioned top three venture capital investments for $127 million:
1 Arch Venture Partners
2 Artis Capital Management
3 CW Group
4 HBM Partners
5 Intel Capital
6 Matrix Partners
7 MPM Capital
8 Nomura Phase4 Ventures
9 OrbiMed Advisors
10 Sequoia Capital
11 TIAA-CREF Healthcare Focus Fund
12 Trinity Ventures
13 Unilever Technology Ventures
14 Venrock Associates
15 WK Technology Fund
A total of 66 equity financings of private and public companies occurred during this reporting period. Each of the 66 equity financings are profiled in a weekly report which include venture financings, private placements, secondary offerings, PIPE’s, and IPO’s.
About www. CapitalHunter. com
Www. CapitalHunter. com is a web-based financial information company that identifies, preserves and electronically disseminates worldwide data on venture capital and other equity financings. Customers utilize the www. CapitalHunter. com searchable database to research newly and historic financings and to identify active investors.
Please visit www. capitalhunter. com and get immediate access. New subscribers can request a free investor analysis.
###
